Status:
UNKNOWN
Obesity-hypoventilation in Metabolic Syndrom Patients
Lead Sponsor:
SOS Oxygene Mediterranee
Conditions:
Metabolic Syndrome
Obesity Hypoventilation Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of the study is to determined the prevalence of obesity-hypoventilation syndrome in patients with metabolic syndrom.
Detailed Description
After being informed about the study and potential risks, patient agreed to participate and undergo : a functional respiratory exploration, an arterial blood gas analyze, and a polygraphy coupled wit...
Eligibility Criteria
Inclusion
- BMI\>30 kg/m2
- no treatment with CPAP nor NIV
Exclusion
- obstructive respiratory disease
- non-treated cardiac dysfunction
Key Trial Info
Start Date :
August 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2025
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04839419
Start Date
August 1 2020
End Date
August 1 2025
Last Update
November 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinique du Château de Vernhes
Bondigoux, France, 31340